First-ever gene therapy for hearing loss gets FDA approval: 'Groundbreaking'
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both pediatric and adult patients after positive results.
DeafMonitor aggregates Deaf-community news and credits every story to its original publisher. This story was reported by Fox News.
Read the full story at Fox News
Read the full story at Fox News